[Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].

Many AML-associated chromosomal abnormalities, such as t(8;21), t(15;17), inv(16), t(9;11), t(9;22) and t(6;9) are well known. The chromosomal aberration of t(16;21)(p11;q22) in AML is rare and it is known to be associated with poor prognosis, young age (median age, 22 yr), and involvement of various subtypes of the French-American-British classification. We report here 2 AML patients with t(16;21)(p11;q22), proved by conventional cytogenetics and/or reverse transcription (RT)-PCR. Erythrophagocytosis by leukemic blasts was observed in both of the cases. One patient was a 24 yr-old male with acute myelomonocytic leukemia. His karyotype was 46,XY,t(16;21)(p11;q22),del(18)(p11.2) and RT-PCR revealed the TLS/FUS-ERG fusion transcripts. Although he received allogeneic peripheral blood stem cell transplantation after the first remission, he died 9 months after the initial diagnosis due to relapse of the disease and graft-versus-host disease. The other patient was a 72 yr-old male with acute myeloid leukemia without maturation. His karyotype was 45,XY,-16,add(21)(q22) and the presence of t(16;21)(p11;q22) was detected by RT-PCR. He was transferred to another hospital with no more follow-up. We suggest that the presence of t(16;21)(p11;q22) and/or TLS/FUS-ERG fusion transcripts has to be considered in cases of AML with erythrophagocytosis.

[1]  Yonggoo Kim,et al.  CD56 antigen expression and hemophagocytosis of leukemic cells in acute myeloid leukemia with t(16;21)(p11;q22) , 2010, International journal of hematology.

[2]  S. Suh,et al.  Unusual type of TLS/FUS-ERG chimeric transcript in a pediatric acute myelocytic leukemia with 47,XX,+10,t(16;21)(p11;q22). , 2006, Cancer genetics and cytogenetics.

[3]  Y. Hayashi,et al.  TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease , 2005, Leukemia & lymphoma.

[4]  Ioannis Panagopoulos,et al.  Atlas of Genetics and Cytogenetics in Oncology and Haematology , 2005 .

[5]  Y. Tsunematsu,et al.  Hemophagocytosis by leukemic blasts in 7 acute myeloid leukemia cases with t(16;21)(p11;q22) , 2000, Cancer.

[6]  S. Hibi,et al.  Hemophagocytosis by leukemic blasts in a case of acute megakaryoblastic leukemia with t(16;21)(p11;q22). , 1999, International journal of hematology.

[7]  T. Kyo,et al.  Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): frequent expression of CD56 and interleukin‐2 receptor α chain , 1999, British journal of haematology.

[8]  B. Calabretta,et al.  TLS/FUS, a pro‐oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL‐mediated leukemogenesis , 1998, The EMBO journal.

[9]  Y. Hayashi,et al.  Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. , 1997, Blood.

[10]  M. Ouchida,et al.  TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. , 1994, Oncogene.

[11]  Y. Hayashi,et al.  An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. , 1994, Cancer research.

[12]  Y. Hayashi,et al.  An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. M. García-Sagredo,et al.  t(16;21) in a Ph positive CML. , 1992, Cancer genetics and cytogenetics.